SCHEMBL21446944

SCHEMBL21446944

CCNc1ncc(C(F)(F)F)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.41
BTK Q06187 1/20 0.41
HDAC3 O15379 3/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC2 Q92769 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40
FLT3 P36888 1/20 0.38
PRKCD Q05655 1/20 0.38
CAMK2B Q13554 1/20 0.38
CAMK2G Q13555 1/20 0.38
CAMK2D Q13557 1/20 0.38
VNN1 O95497 2/20 0.37
PTPN5 P54829 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
CASP1 P29466 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23025737 0.84 HDAC3 (0.38) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL15829268 0.81 ALDH1A1 (0.38) LCKBTKUSP2ALDH1A1CYP1A2
SCHEMBL21984718 0.79 SIGMAR1 (0.42) LCKBTKHDAC3HDAC1HDAC2
SCHEMBL19477233 0.79 SIGMAR1 (0.42) LCKBTKHDAC3HDAC1HDAC2
SCHEMBL24786393 0.79 ESR1 (0.43) HDAC3HDAC1HDAC2HDAC6VNN1
Hydrochloric Acid SCHEMBL28378834 0.78 SIGMAR1 (0.41) LCKBTKHDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL28378836 0.78 SIGMAR1 (0.41) LCKBTKHDAC3HDAC1HDAC2
SCHEMBL18881735 0.77 AOC3 (0.41) HDAC3HDAC1HDAC2HDAC6HPGD
SCHEMBL25075225 0.76 SYK (0.44) BTKHDAC3HDAC1HDAC2HDAC6
SCHEMBL15424474 0.76 ULK1 (0.41) HDAC3HDAC1HDAC2HDAC6USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630775-B1 6-5 FUSED RINGS AS C5a INHIBITORS CHEMOCENTRYX INC (US) 2022-12-14 EP disclosed
WO-2019195159-A1 PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS CHEMOCENTRYX, INC. (US) 2019-10-10 WO disclosed